Determination of dextromethorphan in human plasma using pipette tip solid-phase extraction and gas chromatography-mass spectrometry. 2011

Chika Hasegawa, and Takeshi Kumazawa, and Seisaku Uchigasaki, and Xiao-Pen Lee, and Keizo Sato, and Masaru Terada, and Kunihiko Kurosaki
Department of Legal Medicine, Toho University School of Medicine, 5-21-16 Omorinishi, Tokyo 143-8540, Japan. chika99@med.toho-u.ac.jp

Dextromethorphan was extracted from human plasma samples (100 μL) using MonoTip C(18) tips, which are packed with C(18)-bonded monolithic silica gel that is attached to the inside of the tip. The samples, which contained dextromethorphan and trimeprazine as an internal standard (IS), were mixed with 200 μL of distilled water and 50 μL of 1 mol/L glycine-sodium hydroxide buffer (pH 10). The mixture was extracted to the C(18) phase of the tip by 20 sequential aspirating/dispensing cycles using a manual micropipettor. The analytes retained on the C(18) phase were then eluted with methanol by five sequential aspirating/dispensing cycles. The eluate was injected directly into a gas chromatograph and detected by a mass spectrometer with selected ion monitoring in positive electron ionization mode. An Equity-5 fused silica capillary column (30 m × 0.32 mm i.d., film thickness 0.5 μm) gave adequate separation of the dextromethorphan, IS, and impurities. The recoveries of dextromethorphan and the IS spiked into plasma were >87.4%. The regression equation for dextromethorphan showed excellent linearity from 2.5 to 320 ng/mL of plasma, and the limit of detection was 1.25 ng/mL of plasma. The intraday and interday coefficients of variation were less than 10.5% and 14.7%, respectively. The accuracy ranged from 91.9% to 107%. The validated method was successfully used to quantify the plasma concentration of dextromethorphan in a human subject after oral administration of the drug.

UI MeSH Term Description Entries
D008297 Male Males
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D003915 Dextromethorphan Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (RECEPTORS, N-METHYL-D-ASPARTATE) and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity. d-Methorphan,Delsym,Dextromethorphan Hydrobromide,Dextromethorphan Hydrobromide, (+-)-Isomer,Dextromethorphan Hydrobromide, Monohydrate,Dextromethorphan Hydrochloride,Dextromethorphan, (+-)-Isomer,Racemethorphan,Hydrobromide, Dextromethorphan,Hydrochloride, Dextromethorphan
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D052616 Solid Phase Extraction An extraction method that separates analytes using a solid phase and a liquid phase. It is used for preparative sample cleanup before analysis by CHROMATOGRAPHY and other analytical methods. Extraction, Solid Phase,Extractions, Solid Phase,Solid Phase Extractions
D018691 Excitatory Amino Acid Antagonists Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. Amino Acids, Excitatory, Antagonists,Excitatory Amino Acid Antagonist,Glutamate Antagonist,Glutamate Antagonists,Glutamate Receptor Antagonist,Amino Acid Antagonists, Excitatory,Antagonists, Excitatory Amino Acid,EAA Antagonists,Glutamate Receptor Antagonists,Antagonist, Glutamate,Antagonist, Glutamate Receptor,Antagonists, EAA,Antagonists, Glutamate,Antagonists, Glutamate Receptor,Receptor Antagonist, Glutamate,Receptor Antagonists, Glutamate

Related Publications

Chika Hasegawa, and Takeshi Kumazawa, and Seisaku Uchigasaki, and Xiao-Pen Lee, and Keizo Sato, and Masaru Terada, and Kunihiko Kurosaki
May 1997, Journal of chromatography. B, Biomedical sciences and applications,
Chika Hasegawa, and Takeshi Kumazawa, and Seisaku Uchigasaki, and Xiao-Pen Lee, and Keizo Sato, and Masaru Terada, and Kunihiko Kurosaki
April 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Chika Hasegawa, and Takeshi Kumazawa, and Seisaku Uchigasaki, and Xiao-Pen Lee, and Keizo Sato, and Masaru Terada, and Kunihiko Kurosaki
January 2001, Journal of chromatography. B, Biomedical sciences and applications,
Chika Hasegawa, and Takeshi Kumazawa, and Seisaku Uchigasaki, and Xiao-Pen Lee, and Keizo Sato, and Masaru Terada, and Kunihiko Kurosaki
January 2006, Rapid communications in mass spectrometry : RCM,
Chika Hasegawa, and Takeshi Kumazawa, and Seisaku Uchigasaki, and Xiao-Pen Lee, and Keizo Sato, and Masaru Terada, and Kunihiko Kurosaki
August 1997, Journal of chromatography. B, Biomedical sciences and applications,
Chika Hasegawa, and Takeshi Kumazawa, and Seisaku Uchigasaki, and Xiao-Pen Lee, and Keizo Sato, and Masaru Terada, and Kunihiko Kurosaki
January 2021, Journal of pharmaceutical and biomedical analysis,
Chika Hasegawa, and Takeshi Kumazawa, and Seisaku Uchigasaki, and Xiao-Pen Lee, and Keizo Sato, and Masaru Terada, and Kunihiko Kurosaki
February 2011, Journal of separation science,
Chika Hasegawa, and Takeshi Kumazawa, and Seisaku Uchigasaki, and Xiao-Pen Lee, and Keizo Sato, and Masaru Terada, and Kunihiko Kurosaki
January 2022, Journal of chromatographic science,
Chika Hasegawa, and Takeshi Kumazawa, and Seisaku Uchigasaki, and Xiao-Pen Lee, and Keizo Sato, and Masaru Terada, and Kunihiko Kurosaki
October 2010, Biomedical chromatography : BMC,
Chika Hasegawa, and Takeshi Kumazawa, and Seisaku Uchigasaki, and Xiao-Pen Lee, and Keizo Sato, and Masaru Terada, and Kunihiko Kurosaki
February 2011, Se pu = Chinese journal of chromatography,
Copied contents to your clipboard!